Varia Ventures

MimiVax, LLC is a clinical-stage biotechnology company based in Buffalo, New York, that specializes in developing immunotherapeutic vaccines and targeted therapies for cancer treatment. Founded in 2011, the company focuses on harnessing survivin-targeting technology to create vaccines that address a cell-survival protein commonly found in many cancers. Its lead product, SurVaxM, is a peptide mimic immunotherapeutic vaccine designed to control tumor growth and prevent recurrence, thereby improving patient survival rates. Through its innovative approaches, MimiVax aims to provide effective treatment options for cancer patients by disrupting the mechanisms that allow tumors to thrive.

Buffalo Automation Group, Inc., established in 2014 and based in East Amherst, New York, specializes in developing automated self-navigation technology for ships, waterways, and recreational boats. The company's flagship product, AutoMate, equips existing boats with a forward-facing camera for obstacle detection, enabling boaters to input destinations and receive real-time weather updates. Additionally, AutoMate offers situational awareness, decision support, remote monitoring, data analytics, and cloud-based fleet management platforms, enhancing safety and efficiency in marine navigation.